Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 334171Generated: October 31, 2026

Carbamate → HCID 86667383, compound

https://huagongshe.com/reaction/334171

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCarbamateHCID 276—
ReactantHydrochloric AcidHCID 313—
ReactantMethyl iodideHCID 6328—
ReactantSodium hydrideHCID 24758—
ReactantSodium BicarbonateHCID 516892—
ReactantHCID 86667382HCID 86667382—
SolventWaterHCID 962—
SolventTetrahydrofuranHCID 8028—
ProductHCID 86667383HCID 86667383—

Reaction Conditions

Temperature0 °C

Reaction Steps

A solution of {1-[2-chloro-6-morpholin-4-yl-9-(tetrahydro-pyran-2-yl)-9H-purin-8-yl]-ethyl}-carbamic acid tert-butyl ester (218 mg, 0.47 mmol) in anhydrous THF (15 mL) was cooled to 0° C. Sodium hydride (60% suspension in oil, 22 mg, 0.56 mmol) was added and the mixture was stirred at 0° C. for 30 min. Iodomethane (10 vol. % solution in THF, 0.35 mL, 0.56 mmol) was added and the mixture was stirred for 16 h at RT. The reaction mixture was combined with another mixture, prepared in a similar manner from 210 mg of the carbamate starting-material, and diluted with water. After adjustment to pH7 by addition of 1M aqueous HCl and aqueous sodium bicarbonate, the mixture was extracted three times with ethyl acetate. The combined extracts were dried (Na2SO4), filtered and concentrated in vacuo, to give a 2:1 mixture of the title compound and carbamate starting-material (0.46 g). This mixture was dissolved in anhydrous THF (20 mL) and treated with sodium hydride (19 mg) and iodomethane (10 vol. % solution in THF, 0.29 mL) as before. After addition of more iodomethane (neat, 0.050 mL) and stirring for another 8 h, the reaction mixture was diluted with water, neutralized and extracted as before. The organic extracts were dried (Na2SO4), filtered and concentrated in vacuo. The resulting residue was subjected to flash chromatography (SiO2) gradient 0-20% ethyl acetate in cyclohexane) to give {1-[2-Chloro-6-morpholin-4-yl-9-(tetrahydro-pyran-2-yl)-9H-purin-8-yl]-ethyl}-methyl-carbamic acid tert-butyl ester (316 mg, 72%). LCMS RT=4.48 min, [M+H]+=481/483

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08883799B2
Source datasetuspto-grants-2014_11
ORD IDord-05c2dfe1626548b0a81caadc985e384d
Source noteuspto-grants-2014_11